COR Q2 2021 Earnings — Cencora, Inc. Revenue & Financial Results | Market Cap Arena

CORCencora, Inc.

$68B

Q2 2021 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$49.2B+3.7% YoY

Gross Profit

$1.4B2.9% margin

Operating Income

$703M1.4% margin

Net Income

$435M0.9% margin

EPS (Diluted)

$2.10

QoQ Revenue Growth

-6.4%

Cash Flow

Operating Cash Flow

-$454M

Free Cash Flow

-$540M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$47.0B

Total Liabilities

$47.1B

Stockholders' Equity

-$282M

Cash & Equivalents

$6.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$49.2B	$47.4B	+3.7%
Gross Profit	$1.4B	$1.3B	+10.7%
Operating Income	$703M	$601M	+16.9%
Net Income	$435M	$960M	-54.7%

Revenue Segments

Pharmaceutical Distribution

$47.1B96%

Other Segments

$2.1B4%

Geographic Segments

Other Segments

$2.1B100%